Our results provide preclinical evidence that dysregulation of DNA repair and mitotic fidelity caused by RNF144B deficiency enables lung cancer cells to evade the cytotoxic effects of drugs that cause CIN, DNA damage (through topoisomerase II inhibition) or mitotic alterations. The gene discussed is RNF144B; the disease is lung cancer.